Healthcare Global Enterprises Limited
HealthCare Global Enterprises Limited provides medical and healthcare services in India and internationally. The company offers cancer diagnostics services, including genomics and molecular diagnostics, digital PET, preventive oncology, physical examination, laboratory tests, home health services, digital pathology, and CTC detection; treatment services, such as medical oncology and haemato-oncol… Read more
Healthcare Global Enterprises Limited (HCG) - Total Liabilities
Latest total liabilities as of September 2025: ₹25.92 Billion INR
Based on the latest financial reports, Healthcare Global Enterprises Limited (HCG) has total liabilities worth ₹25.92 Billion INR as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Healthcare Global Enterprises Limited - Total Liabilities Trend (2011–2025)
This chart illustrates how Healthcare Global Enterprises Limited's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Healthcare Global Enterprises Limited Competitors by Total Liabilities
The table below lists competitors of Healthcare Global Enterprises Limited ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Zinzino AB (publ)
PINK:ZNZNF
|
USA | $113.10 Million |
|
Bank Ocbc Nisp Tbk
JK:NISP
|
Indonesia | Rp254.89 Trillion |
|
Secunet Security Networks AG
LSE:0NWC
|
UK | €204.49 Million |
|
MIAPF
PINK:MIAPF
|
USA | $1.52 Billion |
|
Pexip Holding ASA
PINK:PXPHF
|
USA | $618.55 Million |
|
Thai Vegetable Oil Public Company Limited
BK:TVO
|
Thailand | ฿3.48 Billion |
|
Hanza AB
ST:HANZA
|
Sweden | Skr3.08 Billion |
Liability Composition Analysis (2011–2025)
This chart breaks down Healthcare Global Enterprises Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.73 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | 0.18 | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 2.82 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.72 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Healthcare Global Enterprises Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Healthcare Global Enterprises Limited (2011–2025)
The table below shows the annual total liabilities of Healthcare Global Enterprises Limited from 2011 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-03-31 | ₹25.53 Billion | +38.58% |
| 2024-03-31 | ₹18.42 Billion | +27.36% |
| 2023-03-31 | ₹14.47 Billion | +8.29% |
| 2022-03-31 | ₹13.36 Billion | +1.07% |
| 2021-03-31 | ₹13.22 Billion | -27.91% |
| 2020-03-31 | ₹18.33 Billion | +62.05% |
| 2019-03-31 | ₹11.31 Billion | +30.85% |
| 2018-03-31 | ₹8.65 Billion | +17.43% |
| 2017-03-31 | ₹7.36 Billion | +25.85% |
| 2016-03-31 | ₹5.85 Billion | +6.32% |
| 2015-03-31 | ₹5.50 Billion | +35.35% |
| 2014-03-31 | ₹4.07 Billion | -1.55% |
| 2013-03-31 | ₹4.13 Billion | +24.30% |
| 2012-03-31 | ₹3.32 Billion | +56.68% |
| 2011-03-31 | ₹2.12 Billion | -- |